1. Etiology & Epidemiology

  • 2๊ฐ€์ง€ ์งˆ๋ณ‘ ์œ ๋ฐœ : 1) Feline infectious peritonitis virus (FIPV) 2) Feline enteric coronavirus (FECV)
    • FIPV : ๊ณ ์–‘์ด ์ „์—ผ์„ฑ ๋ณต๋ง‰์—ผ ์œ ๋ฐœ
    • FECV : ๊ณ ์–‘์ด ์žฅ์—ผ ์œ ๋ฐœ
  • serotype(ํ˜ˆ์ฒญํ˜•) : ํ•ญ์›์„ฑ์— ๋”ฐ๋ฅธ ๊ตฌ๋ถ„
    • Serotype 1์ด๋“  2๋“  ์žฅ์—ผ/๋ณต๋ง‰์—ผ ์œ ๋ฐœ ๊ฐ€๋Šฅ (serotype๊ณผ ์ž„์ƒ ์ฆ์ƒ์€ ์ง์ ‘์  ์—ฐ๊ด€์„ฑ์ด ์—†์Œ)
  • Biotype(์ƒ๋ฌผํ˜•) : ์ž„์ƒ ์ฆ์ƒ(์žฅ์—ผ/๋ณต๋ง‰์—ผ ๋“ฑ)์— ๋”ฐ๋ผ ๊ตฌ๋ถ„
  • FECV์— ๊ฐ์—ผ๋œ ๊ณ ์–‘์ด์—์„œ ๋ฐ”์ด๋Ÿฌ์Šค์˜ ๋Œ์—ฐ๋ณ€์ด(ํŠนํžˆ 3c, spike protein ์œ ์ „์ž ๋“ฑ)๊ฐ€ ๋ฐœ์ƒํ•˜๋ฉด FIPV๋กœ ์ „ํ™˜๋  ์ˆ˜ ์žˆ์Œ

Check

  • Spike protein์ด ์–ด๋”” ๋ถ™๋ƒ์— ๋”ฐ๋ผ์„œ ์ฆ์ƒ์ด ๋‹ฌ๋ผ์ง.

2. Clinical Findings

FECV

  • ์žฅ์— ๊ฐ์—ผ์„ ์ผ์œผํ‚ด.
  • ๊ฐ์—ผ ํ›„ 3์ผ ์ •๋„๋ฉด ๋ถ„๋ณ€์—์„œ ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ๊ฒ€์ถœ๋  ์ˆ˜ ์žˆ๊ณ , ์ „์—ผ์„ฑ์ด ๋งค์šฐ ๋†’์Œ.
    • ์ง‘๋‹จ ์ƒํ™œํ•˜๋Š” ๊ณ ์–‘์ด๋“ค์€ ๊ฑฐ์˜ ๋‹ค ๊ฐ์—ผ๋œ๋‹ค๋Š” ์—ฐ๊ตฌ๋„ ์žˆ์Œ.
  • ์—ด, ๊ตฌํ† , ์ ์•ก์„ฑ ์„ค์‚ฌ ๋“ฑ ๊ฒฝ๋ฏธํ•œ ์†Œํ™”๊ธฐ ์ฆ์ƒ
  • ๋ฉด์—ญ์ด ๊ดœ์ฐฎ์œผ๋ฉด ๋Œ€๋ถ€๋ถ„ ๋ฉฐ์น  ๋‚ด๋กœ ํšŒ๋ณตํ•จ(self-limiting). Supportive care๋งŒ ํ•ด๋„ ์ž˜ ๋‚ซ๋Š” ํŽธ.
  • ๋ฐ”์ด๋Ÿฌ์Šค ๋ฐฐ์ถœ ํ˜•ํƒœ๊ฐ€ ๋‹ค์–‘ - ๊ณ„์† ๋ฐฐ์ถœํ•˜๋Š” ๊ฒฝ์šฐ๋„ ์žˆ๊ณ , ๊ฐ„ํ—์ ์œผ๋กœ ๋‚˜์˜ค๊ฑฐ๋‚˜, ๋‚˜์•˜๋‹ค๊ฐ€ ๋‹ค์‹œ ๋ฐฐ์ถœ๋˜๋Š” ๊ฒฝ์šฐ๋„ ์žˆ์Œ.

FIP

  • FECV์— ๊ฐ์—ผ๋œ ๊ณ ์–‘์ด์—์„œ ๋Œ์—ฐ๋ณ€์ด๊ฐ€ ์ƒ๊ธฐ๋ฉด FIPV๋กœ ๋ฐ”๋€” ์ˆ˜ ์žˆ์Œ. FIP๋Š” ์ฃผ๋กœ ๋‹ค๋ฌ˜ ๊ฐ€์ •์ด๋‚˜ ์‚ฌ์œก์žฅ์—์„œ ๋งŽ์ด ๋ฐœ์ƒํ•จ.
  • FIP ์ž„์ƒํ˜•์€ ํฌ๊ฒŒ ๋‘ ๊ฐ€์ง€๋กœ ๋‚˜๋‰จ:
Effusive form (wet)Noneffusive form (dry)
๋ฐฐ๊ฐ€ ๋นต๋นตํ•˜๊ฒŒ ์ฐธ
(๋ณต๊ฐ•, ํ‰๊ฐ• ๋“ฑ์— ๋‹จ๋ฐฑ์งˆ์ด ํ’๋ถ€ํ•œ ์•ก์ฒด๊ฐ€ ๊ณ ์ž„)
๋ถ€๋ถ„์ ์ธ ์„ธํฌ ๋งค๊ฐœ์„ฑ ๋ฉด์—ญ์ด ์žˆ๋Š” ํ™˜์ž์—์„œ ๋ฐœ์ƒ.
๋ฉ์–ด๋ฆฌ์ง„ ์œก์•„์ข…์„ฑ ๋ณ‘๋ณ€์ด ๋‹ค์–‘ํ•œ ์žฅ๊ธฐ์— ๋ฐœ์ƒ
(pyogranulomatous or granulomatous)
์ฃผ๋กœ ๋ˆˆ, ๋‡Œ > ์‹ ์žฅ, ์žฅ๊ฐ„๋ง‰, ๊ฐ„ ๋“ฑ
  • ๋‘ ๊ฐ€์ง€ ํ˜•ํƒœ๊ฐ€ ํ˜ผํ•ฉ๋œ ๊ฒฝ์šฐ๋„ ์žˆ์Œ.
  • RT-PCR๋กœ ์ง„๋‹จ ๊ฐ€๋Šฅ (ํŠนํžˆ effusion์—์„œ ๋ฐ”์ด๋Ÿฌ์Šค ๊ฒ€์ถœ ์‹œ ์ž„์ƒ์ ์œผ๋กœ ์œ ์šฉ)

FIP ๋ฐœ๋ณ‘์— ์˜ํ–ฅ์„ ์ฃผ๋Š” ์š”์ธ๋“ค(Factors):

  1. ๋ฐ”์ด๋Ÿฌ์Šค์˜ ๋ณ‘์›์„ฑ(virulence)
  2. ๊ฐ์—ผ๋œ ๋ฐ”์ด๋Ÿฌ์Šค์˜ ์–‘(dose)
  3. ๊ฐ์—ผ ๊ฒฝ๋กœ(route)
  4. ๊ณ ์–‘์ด์˜ ๋ฉด์—ญ ์ƒํƒœ(immune status)
  • 6๊ฐœ์›”๋ น ์ดํ›„์—๋Š” ์ €ํ•ญ์„ฑ์ด ์ฆ๊ฐ€ํ•จ
  • FeLV, ํ˜ธํก๊ธฐ ๊ฐ์—ผ ์‹œ FIP ์œ„ํ—˜ ์ฆ๊ฐ€
  • FIV ์žˆ๋Š” ๊ณ ์–‘์ด์—์„œ FECV shedding์ด ํ›จ์”ฌ ์ฆ๊ฐ€ํ•จ
  1. ์œ ์ „์  ์š”์ธ(genetically)
  • predisposed breeds : ๋ธŒ๋ฆฌํ‹ฐ์‹œ ์ˆํ—ค์–ด, ๋ฐ๋ณธ ๋ ‰์Šค, ์•„๋น„์‹œ๋‹ˆ์•ˆ ๋“ฑ (์ •ํ™•ํ•œ ๊ธฐ์ „์€ ์•„์ง ๋ถˆ๋ช…ํ™•)
  1. ๋™์‹œ ๊ฐ์—ผ(concurrent infection) ์—ฌ๋ถ€
  2. ์ด์ „์— non-FIP inducing feline coronaviruses์— ๋…ธ์ถœ๋œ ์ ์ด ์žˆ๋Š”์ง€ ์—ฌ๋ถ€
  • ์‹คํ—˜์ ์œผ๋กœ๋Š” antibody-dependent enhancement๊ฐ€ ์žˆ์ง€๋งŒ
  • ์‹ค์ œ ์ž์—ฐ ๊ฐ์—ผ์—์„œ๋Š” ๋“œ๋ฌผ๊ฒŒ ๊ด€์ฐฐ๋จ

FIP์˜ Clinical Findings

  • 5์‚ด ๋ฏธ๋งŒ์˜ ์–ด๋ฆฐ ๊ฐœ์ฒด์—์„œ (ํŠนํžˆ <1์‚ด)
  • intact male์—์„œ ๋งŽ์ด ๊ฑธ๋ฆผ
  • FECV์™€ ๋‹ฌ๋ฆฌ FIP๋Š” ์ง‘๋‹จ ๊ฐ์—ผ ์‹ฌํ•˜์ง€ ์•Š์Œ.
  • ๋น„ํŠน์ด์  ์ž„์ƒ ์ฆ์ƒ: ์‹์š•๋ถ€์ง„, ์ฒด์ค‘๊ฐ์†Œ, ์šฐ์šธ ์ „์‹ ์ ์ธ ์ฆ์ƒ์ด ํ”ํ•จ.
  • ๋ˆˆ, ๋‡Œ๋กœ ์ง„ํ–‰: ํฌ๋„๋ง‰์—ผ, ๋งฅ๋ฝ๋ง‰์—ผ / ์‹ ๊ฒฝํ•™์  ์ฆ์ƒ (ํŠนํžˆ dry FIP์—์„œ)

2. Diagnosis

  • ์ฆ์ƒ์— ๋”ฐ๋ผ ๋‹ค์–‘ํ•œ hematology, S-chem, urinalysis.. ๋“ฑ์ด ๋‚˜ํƒ€๋‚จ
  • ํ™•์ง„์€ ์˜ค์ง histopathology(์กฐ์ง๊ฒ€์‚ฌ) ๋กœ๋งŒ ๊ฐ€๋Šฅ!!
  • ์‹ค์ œ๋กœ๋Š” ์ž„์ƒ์  ํŠน์ง• + ์—ฌ๋Ÿฌ ๊ฒ€์‚ฌ๋ฅผ ์ข…ํ•ฉํ•˜์—ฌ ๊ฐ€์ง„๋‹จ (์ž ์ •์ง„๋‹จ)

  • ฮฑ1-acid glycoprotein : ์—ผ์ฆ ํ™•์ธ, FIP๋ฅผ ํ™•์ง„ํ•˜๋Š” ๊ฒƒ ์•„๋‹˜.
  • Feline coronavirus ํ‚คํŠธ
    • ์œ„์–‘์„ฑ ๊ฐ€๋Šฅ, ์œ„์Œ์„ฑ์€ ๊ฑฐ์˜ ๋“œ๋ฌพ (์ด๋ก ์ ์œผ๋กœ ๊ฐ€๋Šฅ)
    • ๊ธธ๋ƒฅ์ด๋Š” ์›ฌ๋งŒํ•˜๋ฉด ์–‘์„ฑ์œผ๋กœ ๋งŽ์ด ๋œธ..
    • Cross-reacting antibodies๋ฅผ ํ˜•์„ฑํ•˜๊ธฐ ๋•Œ๋ฌธ์—, ๋ฐ”์ด๋Ÿฌ์Šค์— ๋…ธ์ถœ๋œ ์ ์ด ์žˆ์„ ๋ฟ FIP๋ฅผ ๊ฐ๋ณ„ํ•  ์ˆ˜ ์—†์Œ.
    • ์–ด๋ฆฐ ๊ณ ์–‘์ด์—์„œ ๋ชจ์ฒด์ดํ–‰ํ•ญ์ฒด๊ฐ€ detect๋  ์ˆ˜ ์žˆ์Œ
  • ICC (Immunocytochemistry) | ์œ„์–‘์„ฑ ๊ฐ€๋Šฅ์„ฑ
  • IHC (Immunohistochemistry) | ์ข€ ๋” ์ง„๋‹จ.. (๋…ธ๋ž€์ƒ‰ ๋ณต์ˆ˜, ํ‰ํ‰ ๋ถ€์€ ์žฅ
  • RT-qPCR |
    • ํ˜ˆ์•ก, ๋ถ„๋ณ€ ์ƒ˜ํ”Œ X
    • Effusion : ๊ฒ€์ฒด๋กœ ์œ ์šฉํ•จ
    • ์‹ ๊ฒฝ/๋ˆˆ ๋ฌธ์ œ ํ™˜์ž์˜ CSF๋„ ๋ฏผ๊ฐ๋„ ๋†’์Œ
์ •๋ฆฌ
Hematologicnonregenerative anemia (normocytic, normochromic)
Neutrophilic leukocytosis, lymphopenia
Thrombocytopenia (DIC ์žˆ์„ ๋•Œ)
๋“œ๋ฌผ๊ฒŒ hemolytic anemia
S-chemHyperglobulinemia
โœ“ < 0.4 ์ด๋ฉด supportive
โœ“ > 0.8 ์ด๋ฉด excluded
ฮฑ1-acid glycoprotein (APP; acute phase protein)
CSFIncreased [Protein]
Increased nucleated cell counts (์—ผ์ฆ์„ธํฌ)
RadiographsPleural/Pericardial/Peritoneal effusions
(Fissure line, ํ๊ฐ€ ๋‘ฅ๋‘ฅ ๋– ๋‹ค๋‹˜)
Decreased serosal detail
Hepatomegaly
Renomegaly
Mesenteric lymphadenopathy
UltrasonographyAbdominal fluids
ํ‚คํŠธ | Feline coronavirus antibody testAntibody-positive
EffusionsSterile, colorless to straw-colored
[Protein] ๋†’์Œ
Albumin/globulin ratio (AGR)
โœ“ AGR 0.5 = ์–‘์„ฑ
โœ“ AGR 1.0 = ์Œ์„ฑ
ํ˜„๋ฏธ๊ฒฝ๋‹ค์–‘ํ•œ ์—ผ์ฆ ์„ธํฌ
๋Œ€๋ถ€๋ถ„ Neutrophils > Matrophages
์ผ๋ถ€๋Š” Macrophages ์šฐ์„ธ
Antibody titiers?Viral RNA๊ฐ€ ๊ฒ€์ถœ๋˜๊ณ , effusion์„ ์œ ๋ฐœํ•  ๋‹ค๋ฅธ ์งˆ๋ณ‘์ด ์—†์œผ๋ฉด
๋ถ„์ž ๊ฒ€์‚ฌ๋ฅผ ๊ผญ ์ˆ˜ํ–‰

Definitive Diagnosis

  1. characteristic histopathologic findings
  2. presence of coronavirus by virus isolation

Treatment

  • ์˜›๋‚ ์—๋Š” ๋ฐฉ๋ฒ•์ด ์—†์—ˆ๋‹ค. ์น˜์‚ฌ์œจ ์‚ฌ์‹ค์ƒ 100%. ์ด๋Ÿฌ์ €๋Ÿฌํ•œ ๋ฐฉ๋ฒ•์„ ์“ฐ์ง€๋งŒ ๋‹ค ์ฃฝ์—ˆ์Œ.

  • ์‹ ์•ฝ ๊ฐœ๋ฐœ๋œ ์ดํ›„๋กœ๋Š” ๋‹ค ์‚ฐ๋‹ค !!

  • ์‹ ์•ฝ | GC376, GS-441524

    • ์ •์‹ ์œ ํ†ต๋˜๋Š” ์•ฝ์ด ์•„๋‹ˆ๋ผ ํ•™๊ต์—์„  ๋ชป ์”€.. ์Œ์„ฑ์ ์œผ๋กœ ์œ ํ†ต๋˜๋Š” ๊ฑฐ ์ผ์Œ. ์‹ ์•ฝ ํ’ˆ๋ชฉํ—ˆ๊ฐ€ ์‹ ์ฒญํ–ˆ์œผ๋‚˜.. ์Œ์„ฑ ์œ ํ†ต์ด ๋„ˆ๋ฌด ๋งŽ์•„์„œ ํšŒ์‚ฌ๊ฐ€ ๋ฌธ ๋‹ซ์Œ.. ๊ทผ๋ฐ ์ง€๊ธˆ ์ธํ„ฐ๋„ท์—์„œ ํŒ”๊ณ  ์žˆ์Œ..
    • ์›๋ž˜๋Š” 12์ฃผ ๋™์•ˆ ๋งค์ผ ์—ฐ๋‹ฌ์•„ ์ฃผ์‚ฌ๋ฅผ ๋งž์•„์•ผ. โ‡’ ์ง€์งˆ์ด ๊ณ„์† ์Œ“์—ฌ์„œ ์šธ๋ฃฉ๋ถˆ๋ฃฉํ•ด์ง. 3์ผ-7์ผ ์ •๋„๋ฉด ์น˜๋ฃŒ๋ฐ˜์‘ ์žˆ์Œ.
    • ์ง€๊ธˆ์€ ๋จน๋Š” ์•ฝ๋„ ๋‚˜์˜ด. ์ดˆ๋ฐ˜์— ์ฃผ์‚ฌ ๋งž๋‹ค๊ฐ€ ๋‚˜์ค‘์—๋Š” ์ง‘์—์„œ ์•ฝ ๋จน์ด๋ฉด.

Zoonotic Aspects

  • ๊ณ ์–‘์ด ์ฝ”๋กœ๋‚˜๋ฐ”์ด๋Ÿฌ์Šค๋Š” ๊ฑด์กฐํ•œ ํ™˜๊ฒฝ์—์„œ ์ตœ๋Œ€ 7์ฃผ๊นŒ์ง€ ์ƒ์กด ๊ฐ€๋Šฅ.
  • ์†Œ๋…์•ฝ์œผ๋กœ ์‰ฝ๊ฒŒ ๋ถˆํ™œ์„ฑํ™”๋จ.
  • FIPV์— ๋…ธ์ถœ๋œ ๋ชจ๋“  ๊ณ ์–‘์ด๊ฐ€ FIP์— ๊ฑธ๋ฆฌ๋Š” ๊ฒƒ์€ ์•„๋‹˜.
  • FIP์— ๋Œ€ํ•œ ๋ฉด์—ญ์€ ์˜๊ตฌ์ ์ด์ง€ ์•Š์Œ.
  • ์œ ์ „์ ์œผ๋กœ FIP์— ์ทจ์•ฝํ•œ ๊ณ ์–‘์ด๋Š” ๋ฒˆ์‹์— ์ฃผ์˜ ํ•„์š”.
  • ๋ฐฑ์‹ (๋น„๊ฐ• ์ ‘์ข…, Primucell FIP)์€ ํšจ๊ณผ๊ฐ€ ๋ถˆํ™•์‹คํ•˜์—ฌ ๋น„๊ถŒ์žฅ(noncore) ๋ฐฑ์‹ ์œผ๋กœ ๋ถ„๋ฅ˜๋จ.
  • ์‚ฌ๋žŒ์—๊ฒŒ ์ „์—ผ๋œ ์‚ฌ๋ก€๋Š” ์—†์Œ(์ธ์ˆ˜๊ณตํ†ต๊ฐ์—ผ ์œ„ํ—˜ ์—†์Œ).